[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"visual-outcome\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:visual-outcome":24},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,3,0,[8,38,65],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":22,"conditions":23,"keywords":4,"overallStatus":25,"whyStopped":4,"lastUpdateSubmitDate":26,"lastUpdatePostDateStruct":27,"startDateStruct":30,"completionDateStruct":32,"leadSponsor":34,"locationsCount":37},"100638354","the-purpose-of-this-clinical-study-is-to-evaluate-optimized-maximum-plus-for-maximum-visual-acuity-mpmva-refractive-technique-and-its-effect-on-visual-performance-100638354",false,"NCT07595432","The Purpose of This Clinical Study is to Evaluate Optimized Maximum Plus for Maximum Visual Acuity (MPMVA) Refractive Technique and Its Effect on Visual Performance.","Clinical Evaluation of Visual Outcomes in LEAP, HIGH, COMP and VISN Extension Cohort","Inclusion Criteria:\n\nMain study:\n\n1. Previously implanted with intraocular lens through 2 previous IOL studies;\n2. Clear intraocular media with no clinically significant opacity, in the investigator's judgment, that would affect visual acuity;\n3. Able to provide informed consent and complete all required study procedures.\n\nExploratory sub-study:\n\n1\\. Additional inclusion criteria: Pseudophakic eyes implanted with one of the IOLs in one eye from 3 previous IOL studies\n\nExclusion Criteria:\n\nMain study:\n\n1. Corrected distance visual acuity (CDVA) worse than 0.2 logMAR (or 20\u002F32 Snellen)\n2. Subjects with ongoing medical conditions or treatment that might impact outcomes during the study visit as determined by the investigator.\n\nExploratory sub-study:\n\n1\\. Additional exclusion criteria: Pseudophakic eyes with oblique residual astigmatism.","ALL","21 Years",{"count":19,"type":20},140,"ESTIMATED","OBSERVATIONAL","This is a prospective, multicenter, parallel groups, non-interventional, examiner masked, comparative clinical study. Patients that participated in previous Hoya studies, and patients previous implanted with Hoya non-toric monofocal IOLs (sub-study only) will be enrolled in the study. The sample size for this study is based on demonstrating the non-inferiority of the mean distance-corrected intermediate visual acuity (DCIVA) in Group 1 (Site 1) compared with Group 2 (Site 2).",[24],"Visual Outcome","RECRUITING","2026-06-03",{"date":28,"type":29},"2026-06-04","ACTUAL",{"date":31,"type":29},"2026-05-13",{"date":33,"type":20},"2026-11-30",{"name":35,"class":36},"Hoya Surgical Optics, Inc.","INDUSTRY",1,{"id":39,"slug":40,"hasResults":11,"nctId":41,"briefTitle":42,"officialTitle":43,"acronym":4,"eligibilityCriteria":44,"healthyVolunteers":11,"sex":16,"minAge":45,"maxAge":46,"enrollmentInfo":47,"targetDuration":49,"studyType":21,"phases":4,"briefSummary":50,"conditions":51,"keywords":4,"overallStatus":25,"whyStopped":4,"lastUpdateSubmitDate":55,"lastUpdatePostDateStruct":56,"startDateStruct":58,"completionDateStruct":60,"leadSponsor":62,"locationsCount":37},"100290540","shanghai-high-myopia-study-100290540","NCT03062085","Shanghai High Myopia Study","Visual Outcome Evaluation and Genetic Analysis: Shanghai High Myopia Study","Inclusion Criteria:\n\n* Clinical diagnosis of cataract\n* Must be able to cooperate with the ophthalmic examination\n\nExclusion Criteria:\n\n* Clinical diagnosis of mental illness\n* Mentally disabled","20 Years","100 Years",{"count":48,"type":20},60000,"5 Years","The purpose of this study is to evaluate the long-term visual outcome of the cataract surgery using a large-scale and comprehensive database of high myopic cataract and age-related cataract patients. The investigators will further investigate into the various genetic and environmental factors that may contribute to the pathogenesis of high myopic cataract.",[52,53,24,54],"High Myopia","Cataract","Genetic Anticipation","2026-05-06",{"date":57,"type":29},"2026-05-11",{"date":59,"type":29},"2015-01-01",{"date":61,"type":20},"2045-12-31",{"name":63,"class":64},"Shanghai High Myopia Study Group","OTHER",{"id":66,"slug":67,"hasResults":11,"nctId":68,"briefTitle":69,"officialTitle":70,"acronym":4,"eligibilityCriteria":71,"healthyVolunteers":11,"sex":16,"minAge":72,"maxAge":45,"enrollmentInfo":73,"targetDuration":75,"studyType":21,"phases":4,"briefSummary":76,"conditions":77,"keywords":4,"overallStatus":25,"whyStopped":4,"lastUpdateSubmitDate":81,"lastUpdatePostDateStruct":82,"startDateStruct":84,"completionDateStruct":86,"leadSponsor":87,"locationsCount":37},"100290627","shanghai-pediatric-cataract-study-100290627","NCT03063216","Shanghai Pediatric Cataract Study","Visual Outcome Evaluation and Genetic Analysis: Shanghai Pediatric Cataract Study","Inclusion Criteria:\n\n* Clinical diagnosis of pediatric cataract\n* Must be able to cooperate with the ophthalmic examination\n\nExclusion Criteria:\n\n* Clinical diagnosis of mental illness\n* Mentally disabled","2 Months",{"count":74,"type":20},10000,"10 Years","The purpose of this study is to evaluate the long-term visual outcome of the cataract surgery using a large-scale and comprehensive database of pediatric cataract participants, including congenital and traumatic cataract. The investigators will further investigate into the various genetic and environmental factors that may contribute to the pathogenesis of pediatric cataract.",[78,79,80,24,54],"Pediatric Cataract","Congenital Cataract","Traumatic Cataract","2024-09-25",{"date":83,"type":29},"2024-09-27",{"date":85,"type":29},"2009-01-01",{"date":61,"type":20},{"name":88,"class":64},"Evidence Based Cataract Study Group"]